Although several markers, such as CD11β [80], CD68 and CD163 [81] and iNOS [82] have been used in migraine and neuroinflammation studies to identify functionally distinct microglial subsets, we selected Iba-1 as the sole microglial marker for this study. Here, CD163 is linked to migraine disorder.